Clinical Trial Update: The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating clarithromycin and rifabutin, alone or in combination, for prevention of MAC or disseminated MAC disease in HIV-infected patients; stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Mycobacterium Avium Complex Infection

Drugs mentioned

• RIFABUTIN (Rifabutin)
• clarithromycin (clarithromycin)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Mycobacterium Avium-intracellulare Infection, HIV Infections | Phase 3 | Status: COMPLETED